UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this technique, the researchers eradicated a devastating blood cancer and certain solid tumor cells by jointly administering drugs ...

from Christopher P. Hess, MD, PhD Professor and Chair, Department of Radiology and Biomedical Imaging UCSF It is with a very heavy heart that I share with you that Sarah J. Nelson, PhD, luminary imaging scientist, friend, and long-time faculty member in the UCSF Department of ...

Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have been considered untreatable are experiencing long-term remissions. But the majority of patients don’t respond to these drugs, and they work far better in some cancers than ...

Tobacco conglomerates that used colors, flavors and marketing techniques to entice children as future smokers transferred these same strategies to sweetened beverages when they bought food and drinks companies starting in 1963, according to a study by researchers at UC San Francisco. The study, which ...

Following the self-disclosure of Jeopardy's Alex Trebek that he is battling pancreas cancer, ABC7 News sat down with UCSF's Dr. Andrew Ko at our Mission Bay campus to discuss common questions about the disease. During the 30-minute Facebook Live broadcast, Dr. Ko discussed common side effects of treatment, ...

The goal of the Biorepository and Tissue Biomarker Technology Shared Resource (BTBMT) is to provide the infrastructure to support the life cycle and QA/QC of high quality biospecimens for cancer research. The multifaceted life cycle includes patient consenting, biospecimen acquisition, processing, storage, and distribution. The ...